Since hyperinsulinemia and increased bioavailability of insulin-like growth factors (IGFs) are typically associated with insulin resistance in patients with T2DM and obesity, researchers have long considered a pivotal role of insulin/IGF signaling in tumors, including PC [36,56,57]. This evidence concerns the gene IGF1 and Obesity.